Shares of automation software company UiPath (NYSE: PATH) rallied 4.7% to $10.40 on Friday, June 26, 2026, as heavy trading volume of 25.3 million shares accompanied the stock's rebound from an intraday low of $9.88. The move higher comes amid the annual reconstitution of the Russell indexes, a major index rebalancing event that typically drives significant trading activity and can create short-term price distortions.
Despite the positive price action, the underlying fundamentals tell a more cautious story. UiPath's guidance indicates net new annual recurring revenue (ARR) of approximately $30 million for the fiscal second quarter at the midpoint, a sharp deceleration from the $49 million added in the first quarter. The company ended April with $1.901 billion in total ARR, and management projects July ARR to land between $1.929 billion and $1.934 billion. To meet the full-year midpoint target near $2.061 billion, UiPath will need to generate roughly $129 million in net new ARR during the second half of the fiscal year, or about $65 million per quarter—more than double the Q2 pace.
CEO Daniel Dines highlighted that ARR grew 12% year-over-year to $1.901 billion, noting that agentic products are "moving from pilot to production." However, the stock continues to trade at levels more typical of a turnaround situation than a high-growth AI software play. The company did post a notable achievement: its first-ever GAAP quarterly profit, with net income of $22.5 million compared to a $22.6 million loss a year earlier. Operating income also turned positive at $28.0 million, versus a $16.4 million operating loss in the prior-year period.
UiPath's balance sheet remains a key support for the stock. The company held $1.416 billion in cash, cash equivalents, and marketable securities as of April 30, representing about 26% of its current market capitalization. During the fiscal first quarter, UiPath repurchased 20.4 million Class A shares at an average price of $11.47, and between May 1 and May 15, it bought back an additional 2.4 million shares at $9.63 per share.
Short interest remains elevated, with 126.25 million shares sold short as of June 15, representing 32.23% of the float. This high level of short interest can amplify both upside and downside moves, as a rally could force short sellers to cover their positions. However, the persistent short interest also reflects skepticism among traders about the company's growth trajectory.
The Russell index reconstitution added another layer of complexity to Friday's trading. FTSE Russell's annual rebalancing, which takes effect after the market close on June 26, saw the market-cap breakpoint between the Russell 1000 and Russell 2000 rise to $5.7 billion from $4.6 billion a year ago. UiPath's intraday market capitalization hovered just below that threshold, within the $2.7 billion to $9.6 billion retention range. Jefferies analyst Steven DeSanctis described the reconstitution as a "really massive trade" with "dramatic" turnover, while Stephens analyst Melissa Roberts called it a "key liquidity day" with estimated trading volume near $150 billion.
Year-to-date, UiPath shares are down 36.64%, and the stock has fallen 18.42% over the past 12 months. The recent bounce brings the price closer to the level where the company executed its May buybacks, though it remains below the average repurchase price of the first quarter. The combination of index-related trading, high short interest, and the need to deliver accelerated ARR growth in the second half makes UiPath a stock to watch closely in the coming months.
